IMDX
Insight Molecular Diagnostics Inc.
4.00$
+1.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
Insight Molecular Diagnostics Inc. (IMDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -22 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.2 | -4.2 | -7.5 | -13 | -12 | -20 | -26 | -36 | -46 | -23 | -21 | -22 | |
| 0.3 | 0.3 | 0.4 | 0.6 | 0.6 | 0.4 | 0.4 | 4.2 | 5.2 | 1.7 | 1.6 | 2.2 | |
| 0.3 | 1.8 | 0.9 | 1.6 | 1.5 | 3.0 | 5.1 | 6.8 | 10 | 6.6 | 1.9 | 2.2 | |
| 3.2 | 2.3 | 2.3 | -0.7 | 1.0 | -1.6 | 2.0 | 0.1 | -1.9 | -4.0 | -1.3 | 2.7 | |
| 0.0 | 0.5 | 0.1 | 0.1 | 0.0 | 0.9 | 1.2 | 2.2 | 4.3 | 0.3 | 0.5 | 3.2 | |
| 1.3 | 0.3 | -0.2 | 0.8 | 0.0 | -12 | -12 | -14 | -4.3 | -0.9 | -0.5 | -3.2 | |
| – | – | – | – | 0.1 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | 0.0 | -0.2 | 0.0 | -1.1 | -5.4 | 0.0 | |
| – | – | – | – | – | – | – | -1.5 | -1.4 | -0.1 | -0.2 | -0.5 | |
| – | 12 | 9.9 | 10.0 | 12 | 48 | 23 | 78 | 36 | 12 | 20 | 28 | |
| 0.2 | 7.7 | 2.2 | -2.6 | 0.4 | 16 | -15 | 28 | -14 | -12 | -0.8 | 3.7 | |
| -1.2 | -4.7 | -7.6 | -13 | -12 | -21 | -27 | -38 | -50 | -24 | -21 | -25 |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.